SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

Attention is centered on SELLASs event-driven Phase 3 REGAL AML trial, which remains officially at 78 of 80 required events and is nearing its final efficacy analysis; traders are also circulating favorable, unofficial comments from AstraZeneca- and J&J-linked professionals describing GPS as a potential game changer. Bulls view the prolonged survival timeline and pending milestone as encouraging, while skeptics cite trial-design and statistical concerns and stress that the outcome remains binary.

Broadcom Inc. is a global technology company, which designs, develops, and supplies semiconductors and infrastructure software solutions. It operates through the Semiconductor Solutions and Infrastructure Software segments. The Semiconductor Solutions segment refers to product lines and intellectual property licensing. The Infrastructure Software segment relates to mainframe, distributed and cyber security solutions, and fibre channel storage area networking business. The company was founded in 1961 and is headquartered in Palo Alto, CA.

Broadcom Inc

Broadcoms upcoming quarterly earnings report is the dominant catalyst, with traders focused on whether AI-chip demand, custom ASIC wins and OpenAIs Jalapeo collaboration will support stronger guidance. Bulls expect the company to validate its AI growth outlook, while bears argue expectations are already elevated and cite debt-financing risks, potential Google share loss to Marvell and weak recent price performance.

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968, and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Speculation about a major foundry partnershipparticularly with Nvidia or SK Hynixis the main stock-specific focus, alongside optimism over Intels 14A progress and strategic government support. Skeptics point to the lack of a confirmed customer announcement, ongoing foundry losses and dilution, while others attribute the weakness to broader pressure from rates, tariffs and the semiconductor selloff.

Enphase Energy, Inc. is a global energy technology company, which engages in the business of designing, developing, manufacturing, and selling home energy solutions that manage energy generation, energy storage, control, and communications on one intelligent platform. It operates through the following geographical segments: the United States, the Netherlands, and Others. The company was founded by Raghuveer R. Belur and Martin Fornage in March 2006 and is headquartered in Fremont, CA.

Enphase Energy Inc

Attention is centered on U.S. restrictions on foreign-made connected power inverters, which traders view as a potential advantage for Enphases domestic manufacturing and solar positioning. The community is divided, with some expecting stronger demand and short covering, while others argue the policy may have limited impact and remain focused on weak solar-sector sentiment, interest rates, and earnings outlook.

Definium Therapeutics, Inc. operates as clinical stage biopharmaceutical company, which engages in developing novel product candidates to treat brain health disorders. The company was founded by Stephen L. Hurst, Scott M. Freeman, Leonard Latchman and Jamon Alexander Rahn on July 26, 2010 and is headquartered in New York, NY.

Definium Therapeutics Inc.

Positive topline Phase 3 Voyage results for DT120 in generalized anxiety disorder, following an earlier Phase 3 depression success, have reinforced the companys late-stage psychedelic-drug thesis and potential NDA path. Traders remain divided between bullish views on the efficacy and upcoming regulatory milestones and concerns that the results were partly priced in, with clinic-monitoring costs, commercialization, dilution, and valuation weighing on sentiment.

Federal National Mortgage Association is a government-sponsored company, which engages in the provision of liquidity for purchases of homes and financing of multifamily rental housing and refinancing existing mortgages. It operates through the Single-Family and Multifamily segments. The Single-Family segment offers liquidity to the mortgage market and increases the availability and affordability of housing for single families. The Multifamily segment includes guaranty fees on mortgages and on multifamily mortgage loans. The company was founded in 1938 and is headquartered in Washington, DC.

Federal National Mortgage Association

Speculation around Fannie Maes release from government conservatorship and a potential NYSE uplisting or IPO is driving attention, with traders citing senior leadership departures, court developments and possible capital-rule changes as supporting signals. Bulls expect a major value-unlocking event, while skeptics point to repeated delays, low volume and the lack of a confirmed timeline.

Costco Wholesale Corp. engages in the provision of operation of membership warehouses through wholly owned subsidiaries. It operates through the following geographical segments: United States, Canada, and Other International Operations. The company was founded by James D. Sinegal and Jeffrey H. Brotman in 1983 and is headquartered in Issaquah, WA.

Costco Wholesale Corp

Costcos monthly sales report showed solid but decelerating comparable-sales growth that missed expectations, triggering a sharp selloff despite continued overall sales growth. Traders are divided between viewing the decline as an overreaction and buying opportunity, while bears argue the companys premium valuation leaves little room for slower growth.

ProShares Trust II - ProShares Ultra VIX Short-Term Futures ETF 1.5x Shares

ProShares Ultra VIX Short-Term Futures ETF

Geopolitical tensions involving Iran, oil-market risk, and expectations of a broader equity correction have traders watching UVXY for a volatility spike. The dominant debate centers on its muted response despite market weakness and elevated uncertainty, with some attributing the behavior to VIX-futures contango, roll decay, and its leveraged structure while others speculate that volatility is being suppressed and remains due for a sharp move.

ProShares Trust - ProShares UltraPro QQQ 3x Shares

ProShares UltraPro QQQ

Hawkish Federal Reserve messaging and rising rate-hike expectations are driving pressure on technology shares and heightened volatility in TQQQ, with traders also monitoring elevated yields, inflation, and Iran-related oil risks. The community is split between bears expecting further downside and dip buyers viewing the selloff as an oversold opportunity.

AST SpaceMobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an intellectual property and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobiles update that BlueBird 14 is complete while BlueBirds 15 and 16 near completion has focused attention on satellite production and launch timing. Traders remain divided: bears cite manufacturing delays, uncertain launch cadence and weak communication as threats to commercialization, while bulls view ongoing satellite and gateway progress as support for the long-term direct-to-device opportunity.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Are DSGR, HLX, ATAI, CRNX Obtaining Fair Deals for their Shareholders?

Are DSGR, HLX, ATAI, CRNX Obtaining Fair Deals for their Shareholders? Are DSGR, HLX, ATAI, CRNX Obtaining Fair Deals for their Shareholders? PR Newswire NEW YORK, Aug. 17, 2026 Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed...

Wall Street Analysts Predict a 31.48% Upside in AtaiBeckley Inc (ATAI): Here's  What You Should Know

The mean of analysts' price targets for AtaiBeckley Inc (ATAI) points to a 31.5% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

LLY Q2 Earnings Top, GLP-1 Drugs Fuel Growth, Sales Guidance Raised

LLY crushes Q2 earnings estimates and lifts its 2026 sales outlook as Mounjaro and Zepbound fuel strong revenue growth and newer drugs add momentum.

Are SOLS, LXP, ATAI Obtaining Fair Deals for their Shareholders?

Are SOLS, LXP, ATAI Obtaining Fair Deals for their Shareholders? Are SOLS, LXP, ATAI Obtaining Fair Deals for their Shareholders? PR Newswire NEW YORK, Aug. 4, 2026 Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed transactions may...

Will Mounjaro & Zepbound Drive Lilly's Q2 Results: Buy, Sell or Hold?

LLY is set to report Q2 results on Aug. 5, with GLP-1 drugs expected to drive growth as investors watch Foundayo's early sales.

Missed AI, Memory Bull Run? Biotech May Be The Next Breakout Trade — But Retail Sentiment Has Never Been Lower 

Equity

Drugmakers have announced 37 biotech acquisitions worth at least $1 billion this year, topping the previous annual record.

How Much Upside is Left in AtaiBeckley Inc (ATAI)? Wall Street Analysts Think 33.33%

The consensus price target hints at a 33.3% upside potential for AtaiBeckley Inc (ATAI). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

Are PSNL, LXP, DSGR, ATAI Obtaining Fair Deals for their Shareholders?

Are PSNL, LXP, DSGR, ATAI Obtaining Fair Deals for their Shareholders? Are PSNL, LXP, DSGR, ATAI Obtaining Fair Deals for their Shareholders? PR Newswire NEW YORK, July 21, 2026 Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed...

GLP-1 Titans Clash: Comparing Eli Lilly and Novo Nordisk

LLY's leadership in obesity drugs, expanding pipeline and stronger growth outlook set it apart as investors weigh it against NVO in 2026.

Billions Flow Into Next-Generation Depression Treatments as Pharma Innovation Accelerates

Billions Flow Into Next-Generation Depression Treatments as Pharma Innovation Accelerates Billions Flow Into Next-Generation Depression Treatments as Pharma Innovation Accelerates PR Newswire NEW YORK, July 21, 2026 Major Depressive Disorder Market Poised for Strong Growth as New Drug Innovations...

Atai Beckley, Inc. is a clinical-stage biopharmaceutical company focused on developing effective, rapid-acting, and convenient mental health treatments. The company is headquartered in New York, NY.

AtaiBeckley Inc.

Neutral Sentiment

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

The S&P 500 ($SPY) is headed towards a positive week. What do you think the index's return will look like next week? Vote and explain your reasoning in the comments.

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Current Price	$7.29
Prev Close	$7.35
Open	$7.34
Dividend Yield	0.00%
50-Day Moving Average	$6.41
Beta	1.45
Avg. Volume	19.79M
PE Ratio	-3.33

52-Week High	$7.45
52-Week Low	$3.27
Market Capitalization	$2.7B
EPS (Annual)	-$2.91
Price to Book	15.26
Revenue Per Employee	$34,948.72

Feed

News

Sentiment

Earnings

Fundamentals

Info